Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PD”

3,602 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,602 results

Not applicableLooking for participantsNCT07589296
What this trial is testing

Robot-Assisted Gait Training vs NMES in Parkinson's Disease

Who this might be right for
Parkinson Disease (PD)
Kanuni Sultan Suleyman Training and Research Hospital 40
Not applicableStudy completedNCT05169827
What this trial is testing

Cerebral Contributions to Symptom Progression in PD

Who this might be right for
Parkinson Disease
Radboud University Medical Center 115
Testing effectiveness (Phase 2)Study completedNCT03665285
What this trial is testing

A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic Solid TumorsLung CancerBreast Cancer+6 more
NextCure, Inc. 109
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07360743
What this trial is testing

Immunotherapy Without Chemotherapy for Advanced Lung Cancer Patients With High PD-L1 Levels

Who this might be right for
Non Small Cell Lung Cancer (Squamous or Non Squamous)
UNICANCER 275
Testing effectiveness (Phase 2)Study completedNCT05661578
What this trial is testing

Evaluate the Safety and Pharmacokinetics of the Intravenous Fixed-Dose Combination (IV FDC) of Tiragolumab and Atezolizumab in Participants With Locally Advanced, Recurrent or Metastatic Solid Tumors

Who this might be right for
PD-L1-selected Solid Tumors
Hoffmann-La Roche 64
Not applicableStudy completedNCT05180643
What this trial is testing

Mindfulness Meditation (MBSR) and Parkinson's Disease (PD)

Who this might be right for
Parkinson Disease
University Hospital, Bordeaux 31
Post-approval studies (Phase 4)Study completedNCT04489888
What this trial is testing

Pembrolizumab (MK-3475) Plus Carboplatin and Paclitaxel as First-line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (MK-3475-B10/KEYNOTE B10)

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
Merck Sharp & Dohme LLC 101
Early research (Phase 1)Study completedNCT03744403
What this trial is testing

CS1001 in Subjects with Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
CStone Pharmaceuticals 24
Not applicableUnknownNCT03078959
What this trial is testing

Prognostic Value of PD-L1 in NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Fondazione Ricerca Traslazionale 350
Early research (Phase 1)Study completedNCT01398748
What this trial is testing

Intranasal Glutathione in Parkinson's Disease

Who this might be right for
Parkinson's Disease (PD)
Bastyr University 34
Large-scale testing (Phase 3)Looking for participantsNCT06170489
What this trial is testing

A Phase III Clinical Study Comparing JS004 Plus Toripalimab With Investigator-Selected Chemotherapy in Patients With PD-(L)1monoclonal Antibody Refractory Classic Hodgkin Lymphoma (cHL)

Who this might be right for
Hodgkin Lymphoma
Shanghai Junshi Bioscience Co., Ltd. 185
Early research (Phase 1)Ended earlyNCT03936959
What this trial is testing

LY3434172, a PD-1 and PD-L1 Bispecific Antibody, in Advanced Cancer

Who this might be right for
Advanced Cancer
Eli Lilly and Company 10
Early research (Phase 1)Looking for participantsNCT07538479
What this trial is testing

Controlled Cold Exposure Combined With PD-1/PD-L1 Immunotherapy in Solid Tumors (NIVALIS)

Who this might be right for
Solid TumorsSolid MalignanciesCold Exposure+1 more
West China Hospital 24
Not applicableStudy completedNCT02756676
What this trial is testing

Impact of Rehabilitation in Quality of Life in PD

Who this might be right for
Parkinson Disease
Ospedale Generale Di Zona Moriggia-Pelascini 250
Not applicableStudy completedNCT01563276
What this trial is testing

Postural Instability in Progressive Supranuclear Palsy

Who this might be right for
Progressive Supranuclear PalsyParkinson's Disease
Oregon Health and Science University 36
Not applicableStudy completedNCT03190018
What this trial is testing

A Feasibility Study of Peritoneal Dialysis With CLS PD, Which Removes Toxins and Maintains a Stable Ultrafiltration by Continuously Regenerating a Recirculating Intraperitoneal Fluid, in Patients With End Stage Renal Disease, ESRD, With PD Therapy.

Who this might be right for
Peritoneal Dialysis
Triomed AB 5
Large-scale testing (Phase 3)Study completedNCT02819518
What this trial is testing

Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355)

Who this might be right for
Triple Negative Breast Cancer (TNBC)
Merck Sharp & Dohme LLC 882
Early research (Phase 1)WithdrawnNCT03196401
What this trial is testing

Durvalumab (Anti-PDL1) Plus Radiation Therapy for the Treatment of Solitary Bone Plasmacytoma

Who this might be right for
Solitary Bone Plasmacytoma
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT06579196
What this trial is testing

Trabedersen (OT-101) With Pembrolizumab for Newly Diagnosed Advanced NSCLC and Positive PD-L1

Who this might be right for
Non-small Cell Lung Cancer
University of Nebraska 45
Not applicableStudy completedNCT01922388
What this trial is testing

Early Versus Late Application of STN DBS to PD Patients With Motor Complications

Who this might be right for
Parkinson Disease
Chen Ling 200
Load More Results